Elhan Webb | Senior Vice President-Investor Relations |
Richard Paulson | President & Chief Executive Officer |
Sohanya Cheng | Chief Commercial Officer |
Reshma Rangwala | Chief Medical Officer |
Mike Mason | Chief Financial Officer |
Kevin Strang | Jefferies |
Abi Gray | R.W. Baird |
Brian Abrahams | RBC Capital Markets |
Eric Joseph | JPMorgan |
Good afternoon. My name is Jason, and I'll be your conference operator today. At this time, I would like to welcome everyone to Karyopharm Therapeutics Third Quarter 2022 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.